|
1
|
Burstein R, Henry NJ, Collison ML, Marczak
LB, Sligar A, Watson S, Marquez N, Abbasalizad-Farhangi M, Abbasi
M, Abd-Allah F, et al: Mapping 123 million neonatal, infant and
child deaths between 2000 and 2017. Nature. 574:353–358. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ostrom QT, Gittleman H, Xu J, Kromer C,
Wolinsky Y, Kruchko C and Barnholtz-Sloan JS: CBTRUS Statistical
Report: Primary Brain and Other Central Nervous System Tumors
Diagnosed in the United States in 2009–2013. Neuro Oncol. 18
(Suppl_5):v1–v75. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Millard NE and De Braganca KC:
Medulloblastoma. J Child Neurol. 31:1341–1353. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Northcott PA, Korshunov A, Witt H,
Hielscher T, Eberhart CG, Mack S, Bouffet E, Clifford SC, Hawkins
CE, French P, et al: Medulloblastoma comprises four distinct
molecular variants. J Clin Oncol. 29:1408–1414. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sirachainan N, Nuchprayoon I,
Thanarattanakorn P, Pakakasama S, Lusawat A, Visudibhan A,
Dhanachai M, Larbcharoensub N, Amornfa J, Shotelersuk K, et al:
Outcome of medulloblastoma in children treated with reduced-dose
radiation therapy plus adjuvant chemotherapy. J Clin Neurosci.
18:515–519. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Doger de Speville E, Robert C,
Perez-Guevara M, Grigis A, Bolle S, Pinaud C, Dufour C, Beaudré A,
Kieffer V, Longaud A, et al: Relationships between regional
radiation doses and cognitive decline in children treated with
cranio-Spinal irradiation for posterior fossa tumors. Front Oncol.
7:1662017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Cuevas LM and Daud AI: Immunotherapy for
melanoma. Semin Cutan Med Surg. 37:127–131. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Barsan V, Ramakrishna S and Davis KL:
Immunotherapy for the treatment of acute lymphoblastic leukemia.
Curr Oncol Rep. 22:112020. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Naylor EC, Desani JK and Chung PK:
Targeted therapy and immunotherapy for lung cancer. Surg Oncol Clin
N Am. 25:601–609. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Morrison AH, Byrne KT and Vonderheide RH:
Immunotherapy and prevention of pancreatic cancer. Trends Cancer.
4:418–428. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lorenzo-Sanz L and Muñoz P:
Tumor-infiltrating immunosuppressive cells in cancer-cell
plasticity, tumor progression and therapy response. Cancer
Microenviron. 12:119–132. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kennedy BC, Showers CR, Anderson DE,
Anderson L, Canoll P, Bruce JN and Anderson RC: Tumor-associated
macrophages in glioma: Friend or foe? J Oncol. 2013:4869122013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Vermeulen JF, Van Hecke W, Adriaansen EJM,
Jansen MK, Bouma RG, Villacorta Hidalgo J, Fisch P, Broekhuizen R,
Spliet WGM, Kool M, et al: Prognostic relevance of
tumor-infiltrating lymphocytes and immune checkpoints in pediatric
medulloblastoma. OncoImmunology. 7:e13988772017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Martin AM, Nirschl CJ, Polanczyk MJ, Bell
WR, Nirschl TR, Harris-Bookman S, Phallen J, Hicks J, Martinez D,
Ogurtsova A, et al: PD-L1 expression in medulloblastoma: An
evaluation by subgroup. Oncotarget. 9:19177–19191. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cavalli FMG, Remke M, Rampasek L, Peacock
J, Shih DJH, Luu B, Garzia L, Torchia J, Nor C, Morrissy AS, et al:
Intertumoral heterogeneity within medulloblastoma subgroups. Cancer
Cell. 31:737–754.e6. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bockmayr M, Mohme M, Klauschen F, Winkler
B, Budczies J, Rutkowski S and Schüller U: Subgroup-specific immune
and stromal microenvironment in medulloblastoma. Oncoimmunology.
7:e14624302018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gieryng A, Pszczolkowska D, Walentynowicz
KA, Rajan WD and Kaminska B: Immune microenvironment of gliomas.
Lab Invest. 97:498–518. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yao M, Ventura PB, Jiang Y, Rodriguez FJ,
Wang L, Perry JSA, Yang Y, Wahl K, Crittenden RB, Bennett ML, et
al: Astrocytic trans-differentiation completes a multicellular
paracrine feedback loop required for medulloblastoma tumor growth.
Cell. 180:502–520.e19. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gandevia B and Tovell A: Declaration of
Helsinki. Med J Aust. 2:320–321. 1964. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Eisen MB, Spellman PT, Brown PO and
Botstein D: Cluster analysis and display of genome-wide expression
patterns. Proc Natl Acad Sci USA. 95:14863–14868. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pham CD, Flores C, Yang C, Pinheiro EM,
Yearley JH, Sayour EJ, Pei Y, Moore C, McLendon RE, Huang J, et al:
Differential immune microenvironments and response to immune
checkpoint blockade among molecular subtypes of murine
medulloblastoma. Clin Cancer Res. 22:582–595. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Graeber MB, Scheithauer BW and Kreutzberg
GW: Microglia in brain tumors. Glia. 40:252–259. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
McGranahan T, Therkelsen KE, Ahmad S and
Nagpal S: Current state of immunotherapy for treatment of
glioblastoma. Curr Treat Options Oncol. 20:242019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Northcott PA, Robinson GW, Kratz CP,
Mabbott DJ, Pomeroy SL, Clifford SC, Rutkowski S, Ellison DW,
Malkin D, Taylor MD, et al: Medulloblastoma. Nat Rev Dis Primers.
5:112019. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pugh TJ, Weeraratne SD, Archer TC,
Pomeranz Krummel DA, Auclair D, Bochicchio J, Carneiro MO, Carter
SL, Cibulskis K, Erlich RL, et al: Medulloblastoma exome sequencing
uncovers subtype-specific somatic mutations. Nature. 488:106–110.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nabors LB, Portnow J, Ammirati M, Baehring
J, Brem H, Brown P, Butowski N, Chamberlain MC, Fenstermaker RA,
Friedman A, et al: Central Nervous System Cancers, Version 1.2015.
J Natl Compr Canc Netw. 13:1191–1202. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Palmer SL, Reddick WE and Gajjar A:
Understanding the cognitive impact on children who are treated for
medulloblastoma. J Pediatr Psychol. 32:1040–1049. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lim M, Xia Y, Bettegowda C and Weller M:
Current state of immunotherapy for glioblastoma. Nat Rev Clin
Oncol. 15:422–442. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Becht E, Giraldo NA, Lacroix L, Buttard B,
Elarouci N, Petitprez F, Selves J, Laurent-Puig P, Sautès-Fridman
C, Fridman WH, et al: Estimating the population abundance of
tissue-infiltrating immune and stromal cell populations using gene
expression. Genome Biol. 17:2182016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liberzon A, Birger C, Thorvaldsdóttir H,
Ghandi M, Mesirov JP and Tamayo P: The Molecular Signatures
Database (MSigDB) hallmark gene set collection. Cell Syst.
1:417–425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lin GL, Nagaraja S, Filbin MG, Suvà ML,
Vogel H and Monje M: Non-inflammatory tumor microenvironment of
diffuse intrinsic pontine glioma. Acta Neuropathol Commun.
6:512018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Murata D, Mineharu Y, Arakawa Y, Liu B,
Tanji M, Yamaguchi M, Fujimoto KI, Fukui N, Terada Y, Yokogawa R,
et al: High programmed cell death 1 ligand-1 expression:
Association with CD8+ T-cell infiltration and poor
prognosis in human medulloblastoma. J Neurosurg. 128:710–716. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Majzner RG, Simon JS, Grosso JF, Martinez
D, Pawel BR, Santi M, Merchant MS, Geoerger B, Hezam I, Marty V, et
al: Assessment of programmed death-ligand 1 expression and
tumor-associated immune cells in pediatric cancer tissues. Cancer.
123:3807–3815. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liang J, Piao Y, Holmes L, Fuller GN,
Henry V, Tiao N and de Groot JF: Neutrophils promote the malignant
glioma phenotype through S100A4. Clin Cancer Res. 20:187–198. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Quail DF and Joyce JA: The
microenvironmental landscape of brain tumors. Cancer Cell.
31:326–341. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Margol AS, Robison NJ, Gnanachandran J,
Hung LT, Kennedy RJ, Vali M, Dhall G, Finlay JL, Erdreich-Epstein
A, Krieger MD, et al: Tumor-associated macrophages in SHH subgroup
of medulloblastomas. Clin Cancer Res. 21:1457–1465. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Maximov V, Chen Z, Wei Y, Robinson MH,
Herting CJ, Shanmugam NS, Rudneva VA, Goldsmith KC, MacDonald TJ,
Northcott PA, et al: Tumour-associated macrophages exhibit
anti-tumoural properties in Sonic Hedgehog medulloblastoma. Nat
Commun. 10:24102019. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Powell AB, Yadavilli S, Saunders D, Van
Pelt S, Chorvinsky E, Burga RA, Albihani S, Hanley PJ, Xu Z, Pei Y,
et al: Medulloblastoma rendered susceptible to NK-cell attack by
TGFβ neutralization. J Transl Med. 17:3212019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nellan A, Rota C, Majzner R,
Lester-McCully CM, Griesinger AM, Mulcahy Levy JM, Foreman NK,
Warren KE and Lee DW: Durable regression of medulloblastoma after
regional and intravenous delivery of anti-HER2 chimeric antigen
receptor T cells. J Immunother Cancer. 6:302018. View Article : Google Scholar : PubMed/NCBI
|
